{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:40:11Z","timestamp":1790707211797,"version":"4.1.0"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"name":"NIH","award":["R21 CA192854"],"award-info":[{"award-number":["R21 CA192854"]}]},{"name":"NIH","award":["R01GM117591"],"award-info":[{"award-number":["R01GM117591"]}]},{"name":"NIH","award":["U54 CA193313"],"award-info":[{"award-number":["U54 CA193313"]}]},{"name":"Columbia-South Africa Training Program","award":["D43 CA153715"],"award-info":[{"award-number":["D43 CA153715"]}]},{"name":"NIH","award":["R21 CA192854-02"],"award-info":[{"award-number":["R21 CA192854-02"]}]},{"name":"NIH","award":["R01GM117591"],"award-info":[{"award-number":["R01GM117591"]}]},{"name":"NIH","award":["U54 CA193313"],"award-info":[{"award-number":["U54 CA193313"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title\/><jats:p>Plasmablastic lymphoma (PBL) is an aggressive B-cell non-Hodgkin lymphoma associated with immunodeficiency in the context of human immunodeficiency virus (HIV) infection or iatrogenic immunosuppression. While a rare disease in general, the incidence is dramatically increased in regions of the world with high HIV prevalence. The molecular pathogenesis of this disease is poorly characterized. Here, we defined the genomic features of PBL in a cohort of 110 patients from South Africa (15 by whole-exome sequencing and 95 by deep targeted sequencing). We identified recurrent mutations in genes of the JAK\u2013STAT signaling pathway, including STAT3 (42%), JAK1 (14%), and SOCS1 (10%), leading to its constitutive activation. Moreover, 24% of cases harbored gain-of-function mutations in RAS family members (NRAS and KRAS). Comparative analysis with other B-cell malignancies uncovered PBL-specific somatic mutations and transcriptional programs. We also found recurrent copy number gains encompassing the CD44 gene (37%), which encodes for a cell surface receptor involved in lymphocyte activation and homing, and was found expressed at high levels in all tested cases, independent of genetic alterations. These findings have implications for the understanding of the pathogenesis of this disease and the development of personalized medicine approaches.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance:<\/jats:title><jats:p>Plasmablastic lymphoma is a poorly studied and extremely aggressive tumor. Here we define the genomic landscape of this lymphoma in HIV-positive individuals from South Africa and identify pervasive mutations in JAK\u2013STAT3 and RAS\u2013MAPK signaling pathways. These data offer a genomic framework for the design of improved treatment strategies targeting these circuits.<\/jats:p><jats:p>See related commentary by K\u00fcppers, p. 23.<\/jats:p><jats:p>This article is highlighted in the In This Issue feature, p. 5<\/jats:p><\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-20-0051","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T18:32:12Z","timestamp":1591813932000},"page":"112-125","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Genomic Characterization of HIV-Associated Plasmablastic Lymphoma Identifies Pervasive Mutations in the JAK\u2013STAT Pathway"],"prefix":"10.1158","volume":"1","author":[{"given":"Zhaoqi","family":"Liu","sequence":"first","affiliation":[{"name":"1Program for Mathematical Genomics, Columbia University, New York, New York."},{"name":"2Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan","family":"Filip","sequence":"additional","affiliation":[{"name":"1Program for Mathematical Genomics, Columbia University, New York, New York."},{"name":"2Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gomez","sequence":"additional","affiliation":[{"name":"1Program for Mathematical Genomics, Columbia University, New York, New York."},{"name":"2Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewaldt","family":"Engelbrecht","sequence":"additional","affiliation":[{"name":"3Department of Haematology and Molecular Medicine, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnum","family":"Meer","sequence":"additional","affiliation":[{"name":"4Department of Oral Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja N.","family":"Lalloo","sequence":"additional","affiliation":[{"name":"3Department of Haematology and Molecular Medicine, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareen","family":"Patel","sequence":"additional","affiliation":[{"name":"3Department of Haematology and Molecular Medicine, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Perner","sequence":"additional","affiliation":[{"name":"5Department of Anatomical Pathology, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfei","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Program for Mathematical Genomics, Columbia University, New York, New York."},{"name":"2Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-4097","authenticated-orcid":false,"given":"Jiguang","family":"Wang","sequence":"additional","affiliation":[{"name":"6Division of Life Science, Department of Chemical and Biological Engineering, Center for Systems Biology and Human Health and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasqualucci","sequence":"additional","affiliation":[{"name":"7Institute for Cancer Genetics."},{"name":"8Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York."},{"name":"9Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[{"name":"1Program for Mathematical Genomics, Columbia University, New York, New York."},{"name":"2Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Willem","sequence":"additional","affiliation":[{"name":"3Department of Haematology and Molecular Medicine, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"2023040512560564400_","first-page":"321","volume-title":"WHO classification of tumors of the hematopoietic and lymphoid tissues","author":"Campo E","year":"2017"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrclinonc.2014.31","article-title":"Diagnosis and management of lymphomas and other cancers in HIV-infected patients","volume":"11","author":"Carbone","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3109\/10428194.2015.1113281","article-title":"Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium","volume":"57","author":"Noy","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12253-013-9632-2","article-title":"Large cell lymphoma: correlation of hiv status and prognosis with differentiation profiles assessed by immunophenotyping","volume":"19","author":"Pather","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/annonc\/mdw684","article-title":"Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group","volume":"28","author":"Tchernonog","year":"2017","journal-title":"Ann Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and-negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1756-8722-2-47","article-title":"Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma","volume":"2","author":"Chang","year":"2009","journal-title":"J Hematol Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/leu.2015.109","article-title":"Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs","volume":"29","author":"Chapman","year":"2015","journal-title":"Leukemia"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno","year":"2017","journal-title":"Mod Pathol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1752-0509-7-S2-S2","article-title":"SAVI: a statistical algorithm for variant frequency identification","volume":"7","author":"Trifonov","year":"2013","journal-title":"BMC Syst Biol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.oraloncology.2011.06.506","article-title":"Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas","volume":"47","author":"Boy","year":"2011","journal-title":"Oral Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"e35337","DOI":"10.7554\/eLife.35337","article-title":"High levels of histones promote whole-genome-duplications and trigger a Swe1(WEE1)-dependent phosphorylation of Cdc28(CDK1)","volume":"7","author":"Maya Miles","year":"2018","journal-title":"Elife"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/leu.2012.367","article-title":"MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma","volume":"27","author":"Wenzel","year":"2013","journal-title":"Leukemia"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J Hematol Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccell.2018.08.006","article-title":"MEF2B instructs germinal center development and acts as an oncogene in B cell lymphomagenesis","volume":"34","author":"Brescia","year":"2018","journal-title":"Cancer Cell"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12094-012-0922-z","article-title":"Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome","volume":"15","author":"Ramsay","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"e1486950","DOI":"10.1080\/2162402X.2018.1486950","article-title":"EBV infection determines the immune hallmarks of plasmablastic lymphoma","volume":"7","author":"Gravelle","year":"2018","journal-title":"Oncoimmunology"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","article-title":"The global landscape of EBV-associated tumours","volume":"9","author":"Shannon-Lowe","year":"2019","journal-title":"Front Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/nar\/gky129","article-title":"Translational profiling of B cells infected with the Epstein-Barr virus reveals 5\u2032 leader ribosome recruitment through upstream open reading frames","volume":"46","author":"Bencun","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"a013029","DOI":"10.1101\/cshperspect.a013029","article-title":"Replication of Epstein\u2013Barr viral DNA","volume":"5","author":"Hammerschmidt","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1128\/JVI.00219-13","article-title":"Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments","volume":"87","author":"Sugimoto","year":"2013","journal-title":"J Virol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2023040512560564400_","article-title":"Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma","author":"Garcia-Reyero","year":"2020","journal-title":"Haematologica"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"12167","DOI":"10.1128\/JVI.01751-14","article-title":"Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells","volume":"88","author":"Cousins","year":"2014","journal-title":"J Virol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.2013.73","article-title":"ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements","volume":"26","author":"Valera","year":"2013","journal-title":"Mod Pathol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"2023040512560564400_","first-page":"549","article-title":"Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fimmu.2019.00156","article-title":"Molecular players in hematologic tumor cell trafficking","volume":"10","author":"Redondo-Mu\u00f1oz","year":"2019","journal-title":"Front Immunol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jcp.56.10.747","article-title":"Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases","volume":"56","author":"Tzankov","year":"2003","journal-title":"J Clin Pathol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2020.02.004","article-title":"CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice","volume":"320","author":"Zhong","year":"2020","journal-title":"J Control Release"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1128\/JVI.00121-15","article-title":"Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr virus lytic activation in B lymphocytes","volume":"89","author":"Koganti","year":"2015","journal-title":"J Virol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/his.13964","article-title":"Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area","volume":"76","author":"Meer S","year":"2019","journal-title":"Histopathology"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ejmg.2017.08.020","article-title":"Efficient detection of chromosome imbalances and single nucleotide variants using targeted sequencing in the clinical setting","volume":"60","author":"Villela","year":"2017","journal-title":"Eur J Med Genet"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbacli.2017.03.006","article-title":"Detection of copy number alterations in cell-free tumor DNA from plasma","volume":"7","author":"Ostrup","year":"2017","journal-title":"BBA Clin"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nbt.1883","article-title":"Full-length transcriptome assembly from RNA-Seq data without a reference genome","volume":"29","author":"Grabherr","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2012.06.008","article-title":"An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions","volume":"12","author":"Arvey","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2023040512560564400_","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2013","journal-title":"Bioinformatics"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/112\/3320796\/112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/1\/112\/3320796\/112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:03:00Z","timestamp":1696230180000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/1\/1\/112\/35193\/Genomic-Characterization-of-HIV-Associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":57,"aliases":["10.1158\/2643-3249.bcd-20-0051"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,10]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-20-0051","relation":{},"ISSN":["2643-3249","2643-3230"],"issn-type":[{"value":"2643-3249","type":"electronic"},{"value":"2643-3230","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,10]]}}}